Ocata Therapeutics Inc fka OCAT

[rumper]

RPE Therapy Works! This FACT Trumps Everything Else

they could only detect hand motion. Within a few days they could actually start to see and count fingers-Lanza


This FACT, is times 10, more important,
than all of the EXAGGERATED problems.

And all problems are being exaggerated,
while phase 1|phase 2A is ignored.

Phase 2B will designed, AND agreed upon
to simply REPLICATE the success of PH1|PH2A.

This is what's being discussed with the FDA
now. (Last comment in the recent CC)

If the FDA doesn't get off the ball, OCAT,
can ditch them and go to the EMA,
which has already provided WRITTEN
guidance for SMD PIVOTAL.

That would be ruthless!

(This is the reality, below. People won't discuss
this because it's immediately branded as HYPE!)

(IT'S NOT HYPE FOLKS, IT'S REALITY, AND SUCCESS)

Dr. Robert Lanza, UConn Stem Cell, April 27, 2015
(Dr. Lanza talking about COMPLETED RPE Ph1|Ph2A)
(The first SMD patient referred to is Cathy from the Charlie
Rose program below)

(Cathy could only detect hand motion!!!, now she can use her computer, and see details on her carved furniture!)

During that follow up period, we actually found in both the SMD and the AMD patients that they had significant overall visual improvement in the treated eyes. Except for one patient, virtually all of the patients either improved or stabilized during that time period. By contrast, the untreated eyes did not show similar improvement in their visual acuity. And this just shows you an overview of the results, so this is the median visual acuity over baseline. So what you are seeing here with the dotted line is the untreated fellow eye. We treated just one eye, so the untreated eye you can see at 6 months and one year, there was no improvement in vision during that time period. By contrast, the eye that we treated with the RPE cells, here you can see that's the solid blue line. There were 15 letters of improvement in these patients. That represents about three lines of visual improvement in these patients. That's a double in visual angle and is generally considered clinically significant. And many of these patients, for instance, they could only detect hand motion. Within a few days they could actually start to see and count fingers. Eventually they could start reading letters on the visual acuity chart and indeed the first SMD patient that we had that could only detect hand motion, now is out over two years and can read 4 lines, 19 letters on the visual acuity chart, and she can use her computer. People can now go to the mall on their own, so this has made a significant difference in the quality of life for many of these patients.
Dr. Robert Lanza, UConn Stem Cell, April 27, 2015

Cathy's Story
Charlie Rose show, 4/22/14
http://www.charlierose.com/watch/60378567